Have you heard about ATX-304? ATX-304, formerly known as O304, is an experimental compound being studied for its potential effects on metabolism, visceral belly fat, insulin sensitivity, and cellular energy. 💡 Fun Fact: Although often discussed alongside peptides, ATX-304 is actually a synthetic small molecule, NOT a peptide! 🔬 HOW DOES ATX-304 WORK? ATX-304 works by activating AMPK (AMP-activated protein kinase), an important enzyme that helps regulate how our bodies produce, store, and use energy. Think of AMPK as one of the body’s metabolic energy regulators! 🌸 POTENTIAL BENEFITS BEING RESEARCHED: 🔥 Visceral Belly Fat: May help reduce fat stored deep around internal organs. ⚡ Metabolic Support: May increase resting energy expenditure, meaning the body burns more energy at rest. 🩸 Insulin Sensitivity: May improve how the body processes glucose and responds to insulin. 🫀 Liver Health: Early research suggests potential reductions in liver fat. 🔋 Cellular Energy: Influences pathways involved in mitochondrial function and energy metabolism. 🧬 Healthy Aging: Researchers are exploring its potential effects on metabolic pathways associated with aging. 📊 WHAT DOES HUMAN RESEARCH SHOW? Early research reported in 2026 involving 23 adults with obesity and prediabetes found promising metabolic changes during an eight-week study. Researchers reported: ✅ Approximately 8% increase in resting metabolic rate ✅ Improvements in liver fat ✅ Reductions in visceral fat ✅ Improvements in triglycerides These findings are preliminary and need confirmation in larger, longer clinical trials. 💉 ATX-304 VS. RETATRUTIDE These two compounds work through very different mechanisms! 🌿 ATX-304: Targets AMPK and cellular energy regulation. Being investigated as an oral treatment for metabolic health. 🌿 Retatrutide: Targets GLP-1, GIP, and glucagon receptors to influence appetite, food intake, and metabolism. Both are investigational compounds, but retatrutide has substantially more human weight-loss research behind it.